American Healthcare REIT
AHR · Health Care REITs
$53.02
0.7%Sabra Health Care REIT
SBRA · Health Care REITs
$19.56
0.2%The short version
- American Healthcare REIT is the larger business, with $2.3B of revenue in fiscal 2025 against $775M for Sabra Health Care REIT, about 2.9 times as much.
- Sabra Health Care REIT grew revenue faster (10.2%, against 9.2%).
- Investors pay more for each dollar of American Healthcare REIT’s earnings: a P/E of 78.0x against 75.2x for Sabra Health Care REIT.
| Latest fiscal year | AHR · FY25 | SBRA · FY25 |
|---|---|---|
| Size | ||
| Market cap | $10.2B | $4.9B |
| Revenue | $2.3B | $775M |
| Free cash flow | — | — |
| Net income | $69.8M | $156M |
| Growth | ||
| Revenue growth | 9.2% | 10.2% |
| 5-year growth | 16.2% | 5.3% |
| Share count change | 27.7% | 3.6% |
| Profitability | ||
| Gross margin | 20.6% | — |
| Operating margin | 18.4% | — |
| Net margin | 3.1% | 20.1% |
| FCF margin | — | — |
| Return on capital | — | 5.1% |
| Return on equity | 2.5% | 5.6% |
| Balance sheet | ||
| Net debt | — | $2.5B |
| Net debt / EBITDA | — | 5.4x |
| Dividends and buybacks | $164M | $290M |
| Valuation & quality | ||
| P/E | 78.0x | 75.2x |
| Piotroski F-score | — | — |
FY16
AHR $3.2M
SBRA $261M
FY17
AHR $33.3M
SBRA $408M
FY18
AHR $84.5M
SBRA $623M
FY19
AHR $121M
SBRA $662M
FY20
AHR $1.1B
SBRA $599M
FY21
AHR $1.1B
SBRA $570M
FY22
AHR $1.4B
SBRA $625M
FY23
AHR $1.9B
SBRA $648M
FY24
AHR $2.1B
SBRA $703M
FY25
AHR $2.3B
SBRA $775M
AHR
SBRA
FY16
AHR −157.2%
SBRA —
FY17
AHR —
SBRA —
FY18
AHR —
SBRA —
FY19
AHR 183.3%
SBRA —
FY20
AHR 20.4%
SBRA —
FY21
AHR 19.0%
SBRA —
FY22
AHR 21.4%
SBRA —
FY23
AHR 16.4%
SBRA —
FY24
AHR 17.6%
SBRA —
FY25
AHR 18.4%
SBRA —
AHR
SBRA
FY16
AHR −$3.6M
SBRA —
FY17
AHR $11.3M
SBRA —
FY18
AHR $11.2M
SBRA —
FY19
AHR $111M
SBRA —
FY20
AHR $211M
SBRA —
FY21
AHR —
SBRA —
FY22
AHR $140M
SBRA —
FY23
AHR —
SBRA —
FY24
AHR —
SBRA —
FY25
AHR —
SBRA —
AHR
SBRA
FY16
AHR —
SBRA 5.8%
FY17
AHR —
SBRA 5.8%
FY18
AHR —
SBRA 6.8%
FY19
AHR —
SBRA 3.2%
FY20
AHR —
SBRA 4.4%
FY21
AHR —
SBRA 3.1%
FY22
AHR —
SBRA 2.1%
FY23
AHR —
SBRA 2.2%
FY24
AHR —
SBRA 4.7%
FY25
AHR —
SBRA 5.1%
AHR
SBRA
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.